Chemical Name: N-(3-(1,3-dioxoisoindolin-2-yl)-2-hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)nitrous amide
Smiles: O=NN(CC(O)CN(C(C1=C2C=CC=C1)=O)C2=O)C3=CC=C(N4C(COCC4)=O)C=C3
Inchi: InChI=1S/C37H34Cl2O10/c1-21-17-25-24-11-10-22-18-23(40)12-13-34(22,2)36(24,39)29(47-31(41)26-7-4-14-44-26)19-35(25,3)37(21,49-33(43)28-9-6-16-46-28)30(20-38)48-32(42)27-8-5-15-45-27/h4-9,12-16,18,20-21,24-25,29H,10-11,17,19H2,1-3H3/b30-20+/t21-,24?,25?,29+,34+,35+,36+,37+/m1/s1
Development and validation of stability indicating UPLC method for the determination of Rivaroxaban in bulk and finished products and identification of degradation products by LCMS
By Ali, Syed Mastan; Ramachandran, D.
From Journal of Applicable Chemistry (Lumami, India) (2021), 10(3), 291-301
Validated LC-MS/MS method for the determination of three genotoxic impurities in rivaroxaban drug substance
By Korlakunta, Vijaya Gouri; Dasari, Vijaya Bharathi; Sharma, Hemant Kumar; Nowduri, Annapurna; Bonige, Kishore Babu; Chavakula, Ramadas
From European Journal of Biomedical and Pharmaceutical Sciences (2020), 7(8), 492-500
Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms
By Souri, Effat; Mottaghi, Siavash; Zargarpoor, Mohammad; Ahmadkhaniha, Reza; Jalalizadeh, Hassan
From Acta Chromatographica (2016), 28(3), 347-361